| |||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Cataracts (prevention) Heart disease (prevention) Macular degeneration (prevention) (lutein, zeaxanthin, lycopene) |
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Carotenoid deficiency is not considered a classic nutritional deficiency like scurvy or beri-beri (severe vitamin C and vitamin B1 deficiencies, respectively). However, given the possible health benefits of carotenoids, most doctors recommend adequate intake. People who do not frequently consume carotenoid-rich foods or take carotenoid supplements are likely to be taking in less than adequate amounts, though optimal levels remain unknown. Also, deficiency may be found in people with chronic diarrhoea or other disorders associated with impaired absorption.
Whether people who already consume a diet high in fruits and vegetables would benefit further from supplementation with a mixture of carotenoids remains unknown. While smokers clearly should not supplement with isolated synthetic beta-carotene, the effect in smokers of taking either natural beta-carotene or mixed carotenoids is not clear.
Nonetheless, based on health-promoting effects associated with these levels in preliminary research, some doctors recommend that most people supplement with up to 25,000 IU (15 mg) per day of natural beta-carotene and approximately 6 mg each of alpha-carotene, lutein, and lycopene.
Carotenoids are generally regarded as safe, based primarily on studies with beta-carotene. Increased consumption of carotenoids may cause to the skin to turn orange or yellow—a condition known as “carotenodermia.” This occurrence is completely benign and is unrelated to jaundice—the yellowing of the skin that can result from liver disease or other causes.
Until more is known, people especially smokers should not supplement with synthetic beta-carotene. Two double-blind studies have shown that supplementation with isolated synthetic beta-carotene may increase the risk of lung cancer in people who smoke.20 21 Moreover, three of four studies have found small increases in the risk of heart disease in people assigned to take synthetic beta-carotene compared with those assigned to take placebo.22 23 24 25
Are there any drug
interactions?
Certain medicines may interact with carotenoids. Refer to drug interactions for a list of those medicines.
1. Krinsky NI. The antioxidant and biological properties of the carotenoids. Ann NY Acad Sci 1998;854:443-7 [review].
2. Russell RM. Physiological and clinical significance of carotenoids. Int J Vitam Nutr Res 1998;68:349-53 [review].
3. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev 1999;57:133-45 [review].
4. Gerster H. Anticarcinogenic effect of common carotenoids. Int J Vitam Nutr Res 1993;63:93-121.
5. Rock CL. Carotenoids: biology and treatment. Pharmacol Ther 1997;75:185-97 [review].
6. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 1997;38:537-56.
7. Albanes D, Heinone OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
8. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
9. Kritchevsky SB. Beta-carotene, carotenoids and the prevention of coronary heart disease. J Nutr 1999;129:5-8 [review].
10. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999;26:746-61.
11. Levy Y, Ben-Amotz A, Aviram M. Effect of dietary supplementation of different beta-carotene isomers on lipoprotein oxidative modification. J Nutr Environ Med 1995;5:13-22.
12. Reaven PD, Ferguson E, Naveab M, Powell FL. Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension. Arterioscler Thromb 1994;14:1162-9.
13. Reaven PD, Khouw A, Beltz WF, et al. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb 1993;13:590-600.
14. Greenburg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699-703.
15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
16. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
17. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
18. Kohlmeier L, Kark JD, Gomez-Gracia E, et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 1997;146:618-26.
19. Argarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998;33:981-4.
20. Albanes D, Heinone OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560–70.
21. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5.
22. Greenburg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699–703.
23. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5.
24. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–35.
25. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145–9.
| |||||||